作者: Jeffrey M. Robbins , Jeremiah Dillon
DOI: 10.7547/14-089
关键词:
摘要: There is increasing pressure from industry to use advanced wound care products and technologies. Many are very expensive but promise reduce overall costs associated with care. Compelling anecdotal evidence provided that inevitably shows wounds failed all other treatments responded positively the subject product. Evidence-based medicine standard by which physician-scientists must make their clinical decisions. In an attempt provide policy makers most current on products, Department of Veteran Affairs conducted Synthesis Program review products. This paper suggests how take this information apply it drive evidence-based improve outcomes fiduciary responsibility.